Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00341757 · ClinicalTrials.gov registry record

Family Health Study (Validation of a Family History of Cancer Questionnaire for Risk Factor Surveillance)

A clinical trial, sponsored by National Cancer Institute (NCI).

Completed
Registry status
5,190
Enrollment target

NCT00341757: Completed study, sponsored by National Cancer Institute (NCI).

NCT00341757 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 5,190 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00341757 has completed, sponsored by National Cancer Institute (NCI).

COMPLETED
Registry status
5,190 participants
Enrollment target

Study Summary

Family history of cancer is an important possible indicator of inherited cancer susceptibility, which has helped identify individuals and families at high risk of inherited cancers in research studies and clinical practice. While there are also various potential uses of family history of cancer data in cancer surveillance, the completeness and accuracy of family history of cancer data collected from the general population is unclear. In an effort to evaluate the feasibility of conducting a national surveillance study to determine the prevalence of family history of cancer in the U.S. population, the Risk Factor Monitoring and Methods Branch will undertake a pilot study, entitled the Family Health Study, that examines issues of data quality. In this study, a family history of cancer questionnaire (FHCQ) will be developed for surveillance purposes and administered to a random digit dial (RDD) sample of households in the state of Connecticut. Positive and negative reports of common cancers in the respondent's families will be validated against records of the Connecticut Tumor Registry (CTR) and other data sources. The objectives are to: 1) assess the agreement between respondent reports of specific cancers in first and second degree relatives and medical record-based reports, as measured by percent concordance; 2) quantify the sensitivity, specificity and predictive value of the FHCQ by cancer site; 3) evaluate the possible predictors of reporting accuracy, including cancer site, year of diagnosis, kinship relation of the relative to the respondent and the frequency and quality of their contact, overall family cohesiveness, respondent's own history of cancer, and demographic factors; 4) describe the completeness and reliability of family structure data. Validation of selected relatives' cancer status will be done through data linkage to the Connecticut Tumor Registry, other selected cancer registries, the National Death Index, Medicare claims data bases, state death

Trial Details

FieldValue
Enrollment Target 5,190 participants
Start Date 2000-09-12
Est. Completion 2011-07-07
National Cancer Institute (NCI)

3,257 total trials

What the finished NCT00341757 record still lists

NCT00341757 is an observational study that tracks outcomes without assigning an intervention. Its 5,190 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 0 interventions.

NCT00341757 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00341757 about?

NCT00341757 is a clinical study titled "Family Health Study (Validation of a Family History of Cancer Questionnaire for Risk Factor Surveillance)". Family history of cancer is an important possible indicator of inherited cancer susceptibility, which has helped identify individuals and families at high risk of inherited cancers in research studies and clinical practice. While there are also various potential uses of family history of cancer data...

What is the current status of trial NCT00341757?

This trial is currently completed. The enrollment target is 5,190 participants. The study started on 2000-09-12. Estimated completion is 2011-07-07.

Who is sponsoring clinical trial NCT00341757?

This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05989308 · 5,200 participants · NA

    MyChart Proxy Outreach to Parents (MyPOP)

  • NCT06008197 · 5,200 participants · Phase 3

    A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

  • NCT05135403 · 5,179 participants

    ASSURE WCD Clinical Evaluation - Post Approval Study (ACE-PAS)

  • NCT06506344 · 5,250 participants · NA

    Syncing Screening and Services for Suicide Prevention Across Health and Justice Systems

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00341757, the US trial registry maintained by the National Library of Medicine. NCT00341757 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.